Annual Cash & Cash Equivalents
$574.96 M
-$57.18 M-9.04%
December 31, 2023
Summary
- As of March 12, 2025, MRVI annual cash & cash equivalents is $574.96 million, with the most recent change of -$57.18 million (-9.04%) on December 31, 2023.
- During the last 3 years, MRVI annual cash & cash equivalents has risen by +$338.78 million (+143.44%).
- MRVI annual cash & cash equivalents is now -9.04% below its all-time high of $632.14 million, reached on December 31, 2022.
Performance
MRVI Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$578.16 M
+$4.99 M+0.87%
September 30, 2024
Summary
- As of March 12, 2025, MRVI quarterly cash and cash equivalents is $578.16 million, with the most recent change of +$4.99 million (+0.87%) on September 30, 2024.
- Over the past year, MRVI quarterly cash and cash equivalents has dropped by -$1.45 million (-0.25%).
- MRVI quarterly cash and cash equivalents is now -8.54% below its all-time high of $632.14 million, reached on December 31, 2022.
Performance
MRVI Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
MRVI Cash And Cash Equivalents Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -9.0% | -0.3% |
3 y3 years | +143.4% | -0.3% |
5 y5 years | +2529.5% | -0.3% |
MRVI Cash And Cash Equivalents Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -9.0% | +4.3% | -8.5% | +34.0% |
5 y | 5-year | -9.0% | +2227.8% | -8.5% | +2240.7% |
alltime | all time | -9.0% | +2529.5% | -8.5% | +2240.7% |
Maravai LifeSciences Holdings Cash And Cash Equivalents History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $578.16 M(+0.9%) |
Jun 2024 | - | $573.17 M(+2.0%) |
Mar 2024 | - | $561.69 M(-2.3%) |
Dec 2023 | $574.96 M(-9.0%) | $574.96 M(-0.8%) |
Sep 2023 | - | $579.61 M(-0.1%) |
Jun 2023 | - | $580.18 M(-7.7%) |
Mar 2023 | - | $628.27 M(-0.6%) |
Dec 2022 | $632.14 M | $632.14 M(+2.4%) |
Sep 2022 | - | $617.45 M(+12.1%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2022 | - | $550.68 M(+27.6%) |
Mar 2022 | - | $431.47 M(-21.7%) |
Dec 2021 | $551.27 M(+133.4%) | $551.27 M(+0.6%) |
Sep 2021 | - | $547.90 M(+46.2%) |
Jun 2021 | - | $374.71 M(+51.3%) |
Mar 2021 | - | $247.68 M(+4.9%) |
Dec 2020 | $236.18 M(+856.2%) | $236.18 M(+550.4%) |
Sep 2020 | - | $36.31 M(+47.0%) |
Dec 2019 | $24.70 M(+13.0%) | $24.70 M |
Dec 2018 | $21.87 M | - |
FAQ
- What is Maravai LifeSciences Holdings annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Maravai LifeSciences Holdings?
- What is Maravai LifeSciences Holdings annual cash & cash equivalents year-on-year change?
- What is Maravai LifeSciences Holdings quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Maravai LifeSciences Holdings?
- What is Maravai LifeSciences Holdings quarterly cash and cash equivalents year-on-year change?
What is Maravai LifeSciences Holdings annual cash & cash equivalents?
The current annual cash & cash equivalents of MRVI is $574.96 M
What is the all time high annual cash & cash equivalents for Maravai LifeSciences Holdings?
Maravai LifeSciences Holdings all-time high annual cash & cash equivalents is $632.14 M
What is Maravai LifeSciences Holdings annual cash & cash equivalents year-on-year change?
Over the past year, MRVI annual cash & cash equivalents has changed by -$57.18 M (-9.04%)
What is Maravai LifeSciences Holdings quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of MRVI is $578.16 M
What is the all time high quarterly cash and cash equivalents for Maravai LifeSciences Holdings?
Maravai LifeSciences Holdings all-time high quarterly cash and cash equivalents is $632.14 M
What is Maravai LifeSciences Holdings quarterly cash and cash equivalents year-on-year change?
Over the past year, MRVI quarterly cash and cash equivalents has changed by -$1.45 M (-0.25%)